In June 2024, Jiangsu Alphamab entered into a research and collaboration agreement with ArriVent BioPharma, Inc. to use Jiangsu Alphamab's proprietary linker-payload (Alphatecan) and glycan-specific ...
WPBN on MSN6h
Women in Northern Michigan use coloring posters to raise addiction awareness after lossSometimes, life puts the right people together at that exact time, and when that happens, great things can follow.A group of ...
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327 ...
Highlights The HHS-OIG released a favorable opinion regarding free drugs offered to patients in financial need for a drug manufactured by the pharmaceutical company offering the assistance The assista ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback